PharmaTalkRadio29 Apr 2020

Advocating for People Managing Hermansky-Pudlak Syndrome

In the third episode of our series highlighting rare diseases, Conference Forum reporter Danny McCarthy sits down with Fernando Albertorio, PhD, to discuss Hermansky-Pudlak Syndrome. Dr Albertorio is co-founder of Sunu, Inc, which creates wearable, IoT and mobile technology that empowers independence for people who a blind and visually impaired. Dr Albertorio is also an advocate for increasing awareness and treatments for managing Hermansky-Pudlak Syndrome (HPS). HPS is an extremely rare autosomal recessive disorder, characterized by albinism, visual impairment, and a platelet dysfunction that results in prolonged bleeding. There are currently 10 known types of HPS. In the episode, Dr Albertorio mentions several websites for more information: HPSNetwork.org, GlobalGenes.org and Sunu.com.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges

For more information, visit theconferenceforum.org

9 Des 202438min

CMO Misunderstandings about Clinical Operations and How to Improve

Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical ope...

5 Des 202433min

How Roche is Maximizing the Impact of Patient Insights in Early Development

For more information, go to theconferenceforum.org

3 Des 202419min

Designing and Developing Drug Delivery for Lower and Middle-Income Countries

This podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and Abb...

21 Nov 202442min